Home > Insider Trading > Filing (0000947871-14-000532)

Filing Details

Accession Number:: 0000947871-14-000532
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-08-18 19:03:58
Reporting Period:: 2014-08-14

Filing Date:: 2014-08-18
Accepted Time:: 2014-08-18 19:03:58
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1326583	Webmd Health Corp.	WBMD	Services-Business Services, Nec (7389)	202783228

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1576147	Peter Anevski	111 Eighth Avenue New York NY 10011	Exec Vp And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2014-08-14	15,000	$47.60	54,546	No	4	S	Direct
Common Stock	Acquisiton	2014-08-15	30,000	$23.61	84,546	No	4	M	Direct
Common Stock	Disposition	2014-08-15	22,588	$48.20	61,958	No	4	F	Direct
Common Stock	Acquisiton	2014-08-15	22,500	$22.40	84,458	No	4	M	Direct
Common Stock	Disposition	2014-08-15	16,669	$48.19	67,789	No	4	F	Direct
Common Stock	Acquisiton	2014-08-15	32,500	$13.15	100,289	No	4	M	Direct
Common Stock	Disposition	2014-08-15	21,056	$48.19	79,233	No	4	F	Direct
Common Stock	Disposition	2014-08-15	25,000	$48.02	54,233	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2014-08-15	30,000	$0.00	30,000	$23.61
Common Stock	Stock Option (Right to Buy)	Disposition	2014-08-15	22,500	$0.00	22,500	$22.40
Common Stock	Stock Option (Right to Buy)	Disposition	2014-08-15	32,500	$0.00	32,500	$13.15

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,000	2018-12-10	No	4	M	Direct
22,500	2022-05-21	No	4	M	Direct
32,500	2022-11-14	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	202	Indirect	By 401(k) Plan

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.60 to $47.64 inclusive. The reporting person undertakes to provide to WebMD Health Corp., any security holder of WebMD Health Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
Mr. Anevski received 7,412 shares of WebMD Common Stock upon net share settlement of his exercise of options to purchase 30,000 shares of WebMD Common Stock, with the remaining 22,588 shares being retained by the issuer to pay the exercise price and to satisfy the minimum tax withholding requirements arising from the exercise.
Mr. Anevski received 5,831 shares of WebMD Common Stock upon net share settlement of his exercise of options to purchase 22,500 shares of WebMD Common Stock, with the remaining 16,669 shares being retained by the issuer to pay the exercise price and to satisfy the minimum tax withholding requirements arising from the exercise.
Mr. Anevski received 11,444 shares of WebMD Common Stock upon net share settlement of his exercise of options to purchase 32,500 shares of WebMD Common Stock, with the remaining 21,056 shares being retained by the issuer to pay the exercise price and to satisfy the minimum tax withholding requirements arising from the exercise.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.68 to $48.11 inclusive. The reporting person undertakes to provide to WebMD Health Corp., any security holder of WebMD Health Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5) to this Form 4.
25% of the shares underlying the option vested on each of 3/31/2010, 3/31/2011, 3/31/2012 and 3/31/2013 (fully vested on 3/31/2013). The date of grant for the options was ten years prior to the expiration date.
25% of the shares underlying the option vest on each of the first, second, third and fourth anniversaries of the date of grant (fully vested on the 4th anniversary of the grant date). The date of grant for the options was ten years prior to the expiration date.
50% of the shares underlying the option vest on each of the first and second anniversaries of the date of grant (fully vested on the 2nd anniversary of the grant date). The date of grant for the options was ten years prior to the expiration date.